Skip to main content

Find Clinical Trials

Home
Conditions
Renal Impairment

Clinical trial condition

Renal Impairment

Explore clinical trials studying Renal Impairment. Study availability and eligibility vary by location and protocol.

210 public trials 9 recruiting studies

Refine in advanced search Browse all conditions

Renal Impairment trial results

Completed

PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers

NCT02039817

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Disease, +6 more
Locations: Avail Clinical Research DeLand, Florida, United States

University of Miami Miami, Florida, United States

View Trial Details

Completed

PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired Patients

NCT02214693

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations: Clinical Trial Center, Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

EVP-6124 Renal Impairment Study

NCT01984723

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations: Jankovcova 1569/2c, 17000 Praha 7, Czechia

Rottenbiller U. 13 H-1077 Budapest, Hungary

View Trial Details

Completed

Fluid Investigation Colloid vs Crystalloid Reg. Renal Hemodynamics and Function

NCT01729364

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations: Sahlgrenska University Hospital/Thoracic Intensive Care Gothenburg, Västra Götaland County, Sweden

View Trial Details

Completed

A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects

NCT02199379

Conditions: Disease Severity, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +6 more
Locations: Orlando, Florida, United States

Minneapolis, Minnesota, United States

Knoxville, Tennessee, United States

View Trial Details

Completed

Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects

NCT01796938

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Healthy, +6 more
Locations: 1 Cologne, Germany

2 Rendsburg, Germany

View Trial Details

Completed

Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function

NCT01372826

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations: Research Site Anaheim, California, United States

Research Site Orlando, Florida, United States

Research Site Overland Park, Kansas, United States

View Trial Details

Completed

A Single-Dose Study to Assess the Pharmacokinetics of Cabozantinib (XL184) Capsules in Subjects With Impaired Renal Function

NCT01761773

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Healthy, +6 more
Locations: Miami, Florida, United States

Orlando, Florida, United States

Neptune City, New Jersey, United States

View Trial Details

Completed

An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment

NCT01770652

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations: Hôpital Maisonneuve-Rosemont Montreal, Quebec, Canada

Algorithme Pharma Inc. Mount Royal, Quebec, Canada

View Trial Details

Completed

Study to Evaluate GLPG0634 in Subjects With Renal Impairment Compared to Healthy Subjects

NCT02084199

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +5 more
Locations: CRS Clinical Research Services Kiel GmbH Kiel, Germany

View Trial Details